Abiopharma

🔍 FLETCHER R JOHN (Executive)

Company: ClearPoint Neuro, Inc. (CLPT)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 422 shares of Common Stock at $13.68 per share (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: false | shares_owned_after: 116,662.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at December 31, 2025.